LB Pharmaceuticals Inc (LBRX) — Dilution Risk Analysis
Current Snapshot
LB Pharmaceuticals Inc (LBRX) has a DilutionWatch score of 47/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 47/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: XBRL 1, 424B3 1, EFFECT 1, S-1 1, 3 1, 4 2, 8-K 1.
| Form | Filed | Accession |
|---|---|---|
| xbrl | 2026-06-30 | xbrl-3820-xbrl_warrant |
| 424B3 | 2026-04-14 | 0001193125-26-155011 |
| EFFECT | 2026-04-14 | 9999999995-26-001186 |
| S-1 | 2026-04-06 | 0001193125-26-143724 |
| 3 | 2026-03-10 | 0001992908-26-000005 |
| 4 | 2026-03-10 | 0001992908-26-000007 |
| 4 | 2026-02-10 | 0001193125-26-044776 |
| 8-K | 2026-02-05 | 0001193125-26-038539 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $100,000,000 | Source |
| Cash runway | 111 months | Source |
| Three-year share count growth | 42.67% | Source |
DilutionWatch Analysis
- Risk Level
- MEDIUM (Score: 47/10) Source
- Cash Runway
- 111 months Source
- Shelf Registration Capacity
- $100,000,000 Source
- Share Count Growth (3-Year)
- 42.67% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.